Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study

被引:247
作者
van Haren, Neeltje E. M.
Pol, Hilleke E. Hulshoff
Schnack, Hugo G.
Cahn, Wiepke
Mandl, Rene C. W.
Collins, D. Louis
Evans, Alan C.
Kahn, Rene S.
机构
[1] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, NL-3584 CX Utrecht, Netherlands
[2] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
关键词
schizophrenia; MRI; follow-up; voxel-based morphometry; frontal lobe; antipsychotic medication;
D O I
10.1038/sj.npp.1301347
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent volumetric magnetic resonance imaging ( MRI) studies have suggested brain volume changes in schizophrenia to be progressive in nature. Whether this is a global process or some brain areas are more affected than others is not known. In a 5-year longitudinal study, MRI whole brain scans were obtained from 96 patients with schizophrenia and 113 matched healthy comparison subjects. Changes over time in focal gray and white matter were measured with voxel-based morphometry throughout the brain. Over the 5-year interval, excessive decreases in gray matter density were found in patients in the left superior frontal area (Brodmann areas 9/10), left superior temporal gyrus (Brodmann area 42), right caudate nucleus, and right thalamus as compared to healthy individuals. Excessive gray matter density decrease in the superior frontal gray matter was related to increased number of hospitalizations, whereas a higher cumulative dose of clozapine and olanzapine during the scan interval was related to lesser decreases in this area. In conclusion, gray matter density loss occurs across the course of the illness in schizophrenia, predominantly in left frontal and temporal cortices. Moreover, the progression in left frontal density loss appears to be related to an increased number of psychotic episodes, with atypical antipsychotic medication attenuating these changes.
引用
收藏
页码:2057 / 2066
页数:10
相关论文
共 42 条
  • [1] ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615
  • [2] REGIONAL BRAIN ABNORMALITIES IN SCHIZOPHRENIA MEASURED WITH MAGNETIC-RESONANCE-IMAGING
    ANDREASEN, NC
    FLASHMAN, L
    FLAUM, M
    ARNDT, S
    SWAYZE, V
    OLEARY, DS
    EHRHARDT, JC
    YUH, WTC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (22): : 1763 - 1769
  • [3] At issue: Stress, hippocampal neuronal turnover, and neuropsychiatric disorders
    Arango, C
    Kirkpatrick, B
    Koenig, J
    [J]. SCHIZOPHRENIA BULLETIN, 2001, 27 (03) : 477 - 480
  • [4] Voxel-based morphometry - The methods
    Ashburner, J
    Friston, KJ
    [J]. NEUROIMAGE, 2000, 11 (06) : 805 - 821
  • [5] Why voxel-based morphometry should be used
    Ashburner, J
    Friston, KJ
    [J]. NEUROIMAGE, 2001, 14 (06) : 1238 - 1243
  • [6] Voxel-based morphometry should not be used with imperfectly registered images
    Bookstein, FL
    [J]. NEUROIMAGE, 2001, 14 (06) : 1454 - 1462
  • [7] Brain volume changes in first-episode schizophrenia - A 1-year follow-up study
    Cahn, W
    Pol, HEH
    Lems, EBTE
    van Haren, NEM
    Schnack, HG
    van der Linden, JA
    Schothorst, PF
    van Engeland, H
    Kahn, RS
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (11) : 1002 - 1010
  • [8] CAUDATE NUCLEI VOLUMES IN SCHIZOPHRENIC-PATIENTS TREATED WITH TYPICAL ANTIPSYCHOTICS OR CLOZAPINE
    CHAKOS, MH
    LIEBERMAN, JA
    ALVIR, J
    BILDER, R
    ASHTARI, M
    [J]. LANCET, 1995, 345 (8947): : 456 - 457
  • [9] CHAKOS MH, 1994, AM J PSYCHIAT, V151, P1430
  • [10] Automatic 3-D model-based neuroanatomical segmentation
    Collins, DL
    Holmes, CJ
    Peters, TM
    Evans, AC
    [J]. HUMAN BRAIN MAPPING, 1995, 3 (03) : 190 - 208